Biomodal has launched a Certified Service Provider (CSP) program to expand global access to its Duet multiomics sequencing solutions, according to the company. The program establishes a network of validated service organizations that are trained and certified to use Biomodal’s Duet evoC and Duet +modC technologies.
Under the program, CSPs will deliver multiomic data and analyses to clients in fields such as disease detection, therapy monitoring, and mechanistic biology. Biomodal said the certification ensures consistency and quality of data across its network.
Initial participants include prominent research service providers such as Eurofins Clinical Enterprise (USA), Garvan Institute of Medical Research (Australia), Life & Brain (Germany), McGill Genome Center (Canada), MOgene (USA), University of Michigan Medical School (USA), University of Minnesota Genomics Center (USA), and Zymo Research (USA).
Biomodal claims the CSP program offers these partners a competitive advantage by enabling them to provide customers high-quality multiomic data using the company’s technology. The launch is intended to help scale the adoption of its multiomics platform while maintaining standardization across service sites.
Biomodal describes itself as a life sciences technology and analytics firm focused on enabling integrated genetic and epigenetic profiling from low-input DNA in a single workflow, without harsh chemical treatments or complex computing pipelines.
